Search
ALPHAGAN 0.2 %, Collyre
Details
| --- | Description |
|---|---|
| Pack | Flacon de 5 ml |
| Strength (Dosage) | 0.2 % |
| Laboratory | AFRIC-PHAR |
| Ingredients | Brimonidine |
| Therapeutic class | Antiglaucomateux |
| ATC code | S01EA05 |
| PPH | $5.70 |
| PPV | $9.15 |
| Refundable | Yes |
| Refund base | $9.15 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | Réduction de la pression intraoculaire élevée (PIO) chez les patients ayant un glaucome à angle ouvert ou une hypertension oculaire. - En monothérapie chez les patients présentant une contre-indication aux bêtabloquants à usage local. - En association à d'autres traitements diminuant la pression intraoculaire dans le cas où une monothérapie ne permet pas d'atteindre la PIO cible. |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications with one or more of the ingredients above
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem